Literature DB >> 12375035

Assessment of carcinoma in the sublingual region based on magnetic resonance imaging.

Jun-Ichi Asaumi1, Hiroshi Shigehara, Hironobu Konouchi, Yoshinobu Yanagi, Miki Hisatomi, Hidenobu Matsuzaki, Kanji Kishi.   

Abstract

In the present study, we attempted to diagnose and detect the extent of tumors in the sublingual region using magnetic resonance imaging (MRI) and dynamic MRI. MRI with or without gadopentetate dimeglumine (Gd-DTPA)-enhancement in seven lesions of the sublingual regions was performed. The seven lesions included four cases of mucoepidermoid carcinoma (mucoepidermoid Ca), two cases of adenoid cystic carcinoma (ACC), and one case of squamous cell carcinoma (SCC). Whether the tumor was malignant or benign, as well as the differential diagnosis, could not be determined on the basis of the MR signals, even when enhancement was performed. Dynamic MRI was performed in five cases, two cases of ACC, two cases of mucoepidermoid Ca, and one case of SCC. The dynamic MRI showed a rapid enhancement at 30-45 sec in all five cases before the normal sublingual gland began to be enhanced. The early phases at 30-45 sec of the dynamic MRI in five cases showed marked enhancement before the normal sublingual glands were enhanced, and therefore could clearly show the extent of the lesions. In conclusion, the dynamic MRI may be useful in differentiating malignant from benign tumors, and in detecting the extent of the tumors in the sublingual carcinomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12375035

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  2 in total

1.  Radiological and clinical features of peripheral keratocystic odontogenic tumor.

Authors:  Ling Zhu; Jie Yang; Jia-Wei Zheng
Journal:  Int J Clin Exp Med       Date:  2014-01-15

2.  Carcinoma ex pleomorphic adenoma of the sublingual gland: a case report.

Authors:  Yasunori Ariyoshi; Masashi Shimahara; Toshiyuki Konda; Motomu Tsuji
Journal:  Int J Oral Sci       Date:  2012-01-12       Impact factor: 6.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.